Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

ARCUTIS BIOTHERAPEUTICS INC (ARQT)

277 + Investors. Track Smart Money conviction in ARQT. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +43
Streak
2Q ▲
Buyers last Q
64%

Smart Money Signals — ARQT

Based on 268 hedge funds · latest filing: 2025 Q4 · updated quarterly

📈

Buying streak — 2 quarters in a row

last 6Q
For 2 consecutive quarters, more hedge funds added ARQT than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
268 hedge funds hold ARQT right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +35% more funds vs a year ago

fund count last 6Q
+70 new funds entered over the past year (+35% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟢

More buyers than sellers — 64% buying

176 buying100 selling
Last quarter: 176 funds were net buyers (72 opened a brand new position + 104 added to an existing one). Only 100 were sellers (71 trimmed + 29 sold completely). A clear majority buying is a strong confirmation signal.
📈

More new buyers each quarter (+39 vs last Q)

new funds entering per quarter
Funds opening a new ARQT position: 64 → 33 → 33 → 72. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
📌

Mixed — 39% long-term, 28% new

■ 39% conviction (2yr+) ■ 34% medium ■ 28% new
Of the 268 current holders: 104 (39%) held >2 years, 90 held 1–2 years, and 74 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.
💰

Value +57% but shares only +3% — price-driven

Value
+57%
Shares
+3%
Last quarter: the total dollar value of institutional holdings rose +57%, but actual share count only changed +3%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
➡️

Steady discovery — ~72 new funds/quarter

47 → 64 → 33 → 33 → 72 new funds/Q
New funds entering each quarter: 64 → 33 → 33 → 72. Consistent flow of new institutional buyers without clear acceleration or slowdown.
🏛️

Deep conviction — 47% of holders stayed 2+ years

■ 47% veterans ■ 17% 1-2yr ■ 36% new
Of 277 current holders: 129 (47%) have held for over 2 years without selling. These are not momentum buyers — they have lived through drawdowns and stayed. A large veteran base acts as a stabilizing force during selloffs.
✅

Strong quality — 35% AUM from major funds

35% from top-100 AUM funds
34 of 268 holders rank in the top 100 by AUM, accounting for 35% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
4.0
out of 10
Moderate Exit Risk
Exit risk score 4.0/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — ARQT

In 2025 Q4, 176 hedge funds were net buyers of ARQT (72 opened a new position, 104 added to an existing one), while 100 reduced or exited (71 trimmed, 29 sold completely) — a 64% buyer ratio, indicating clear institutional accumulation. Net buying has persisted for two consecutive quarters, a positive momentum signal. 35% of total institutional value in ARQT is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: +43 funds (more new holders than closures). Total institutional holders: 268.

Hedge Fund Ownership: ARQT

How many hedge funds hold ARQT — quarterly history vs. share price
Quarterly hedge fund ownership of ARQT vs. share price

Market Analysis: ARQT

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: ARQT

Healthcare Biotechnology

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Smart Money Signal ?
Broad Consensus, Selective Conviction

Many quality funds hold this stock, but top-tier positions remain relatively small.

51 top-rated funds 6 high-conviction
Consensus
7.5
/ 10
breadth
×
Elite
3.9
/ 10
conviction
Hedge Fund Positioning: ARQT
2026 Q1 Stats Unlock in 5 days 277 + Investors

Track Smart Money conviction in ARQT. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2025 Q4) Prior (2025 Q3) Change
Funds Holding 277 235 17.87%
13F Shares 130M 126M 3.43%
Total Value $3.73B $2.37B 57.34%
New Positions 72 33 +39
Increased Positions 121 94 +27
Closed Positions 29 25 +4
Reduced Positions 84 105 -21
Total Calls 5 6 -16.67%
Total Puts 5 5 -
PUT/CALL Ratio 1.0 0.83 Neutral

Statistics: ARQT

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

277 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in ARQT. Verified SEC 13F-HR filings.

QUARTER:
Top 25 institutional holders of ARQT — 2025 Q4 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Pivotal bioVenture Partners Investment Advisor LLC 11.42% 1,355,892 $31.9M
2 Privium Fund Management B.V. 1.57% 320,972 $7.6M
3 Tejara Capital Ltd 1.29% 166,191 $3.9M
4 FISHMAN JAY A LTD/MI 1.19% 566,730 $13.4M
5 1492 Capital Management LLC 1.06% 118,156 $2.8M
6 MYDA Advisors LLC 0.93% 240,000 $5.7M
7 Penn Capital Management Company, LLC 0.61% 333,130 $7.9M
8 ESSEX INVESTMENT MANAGEMENT CO LLC 0.54% 143,934 $3.4M
9 Jackson Creek Investment Advisors LLC 0.48% 68,646 $2K
10 DRIEHAUS CAPITAL MANAGEMENT LLC 0.39% 2,226,029 $52.4M
11 Perpetual Ltd 0.33% 909,546 $21.4M
12 PSP Research LLC 0.33% 19,700 $464K
13 PEREGRINE CAPITAL MANAGEMENT LLC 0.27% 306,272 $7.2M
14 MFA Wealth Services 0.25% 16,196 $382K
15 ZEVENBERGEN CAPITAL INVESTMENTS LLC 0.24% 357,490 $8.4M
16 GW&K Investment Management, LLC 0.21% 988,387 $23K
17 Virtus Investment Advisers, LLC 0.19% 29,092 $685K
18 Phocas Financial Corp. 0.19% 50,299 $1.2M
19 Elevated Financial Group LLC 0.16% 20,543 $484K
20 Candriam S.C.A. 0.13% 1,086,651 $25.6M
21 Hillsdale Investment Management Inc. 0.12% 188,220 $4.4M
22 Legato Capital Management LLC 0.10% 45,350 $1.1M
23 Invst, LLC 0.09% 35,205 $829K
24 KORNITZER CAPITAL MANAGEMENT INC /KS 0.09% 175,870 $4.1M
25 JENNISON ASSOCIATES LLC 0.08% 4,980,770 $117.3M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — ARCUTIS BIOTHERAPEUTICS INC (ARQT)

What does the Smart Money Trend signal show for ARQT?

Buying streak — 2 quarters in a row: For 2 consecutive quarters, more hedge funds added ARQT than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for ARQT?

More buyers than sellers — 64% buying: Last quarter: 176 funds were net buyers (72 opened a brand new position + 104 added to an existing one). Only 100 were sellers (71 trimmed + 29 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for ARQT holders?

Strong quality — 35% AUM from major funds: 34 of 268 holders rank in the top 100 by AUM, accounting for 35% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held ARQT?

Mixed — 39% long-term, 28% new: Of the 268 current holders: 104 (39%) held >2 years, 90 held 1–2 years, and 74 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.